DS5 DSIP Broad compatibility 99% purity specification Factory direct price5 mg/vial 10 mg/vial

  Product Detail  

As key substances involved in various cellular functions of the human body, peptides can not only enter cells to regulate their functional activities after synthesis, but also act as neurotransmitters in the body to undertake the responsibility of information transmission. At the same time, peptides are also efficient "transport carriers" that can accurately deliver nutrients such as vitamins, biotin, calcium and various trace elements to the cells, organs and tissues of the human body. In addition, they are important physiological regulators of the human body, which can comprehensively regulate physiological functions, enhance and exert the body's own physiological activity, and possess irreplaceable biological functions.

Name:Rain

Whatsapp:+852 69948372

Email:rain@anymang.cn

Triple Agonist Design :

GLP-1 receptor: Retatrutide delays gastric emptying, suppress appetite, and promote secretion.

GIP receptor: Retatrutide enhances sensitivity and regulate central satiety signals.

Glucagon receptor (GCGR): Retatrutide activates liver energy metabolism, promote lipolysis and glycogenolysis, and increase basal metabolic rate.

The triple synergistic effect increases energy consumption while reducing energy intake, significantly improving weight loss effects.

Mechanism of Action and Molecular Structure of Retatrutide:

1)Triple Agonist Design
- GLP-1 receptor: Retatrutide delays gastric emptying, suppress appetite, and promote secretion.
- GIP receptor: Retatrutide enhances insulin sensitivity and regulate central satiety signals.
- Glucagon receptor (GCGR): Retatrutide activates liver energy metabolism, promote lipolysis and glycogenolysis, and increase basal metabolic rate.
The triple synergistic effect increases energy consumption while reducing energy intake, significantly improving weight loss effects.

2) Structural Optimization
- Based on the GIP skeleton modification, non-natural amino acids (such as α-methylleucine at position 13) are introduced to enhance receptor affinity.
- The half-life is extended to 7 days through fatty acid side chain modification